Healthy volunteers test new drug formulas in Early-Stage safety trial

This early-stage trial tests the safety and how the body processes two versions of an experimental drug, DW4421 and DW4421S, in 38 healthy adults aged 19 to 50. Participants receive a single dose of each drug in random order and are monitored for side effects and drug levels in the blood. The study does not aim to treat any disease.